CD5删除增强了采用T细胞疗法的抗瘤活性
Ruchi P Patel1,2,3, Guido Ghilardi1,2,3, Yunlin Zhang1,2,3
1Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Science immunology
|July 19, 2024
概括
删除CD5增强了仿真抗原受体 (CAR) T细胞治疗对抗癌症的有效性. CD5淘汰会促进CAR T细胞的功能,扩张和持久性,在临床前模型中改善抗瘤效果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 基因编辑 基因编辑
背景情况:
- 化学抗原受体 (CAR) T细胞疗法显示出希望,但面临着疾病进展和在固体瘤和某些血液癌症中有限的疗效等挑战.
- 卡尔-T细胞功能障碍,扩张不良和缺乏持久性是成功采用T细胞免疫疗法的关键障碍.
研究的目的:
- 研究CD5在CAR T细胞功能中的作用及其作为增强CAR T细胞介导抗瘤作用的点的潜力.
- 评估CD5淘汰对CAR T细胞激活,效应器功能和在临床前癌症模型中的治疗疗效的影响.
主要方法:
- 利用CRISPR-Cas9基因编辑来淘汰 (KO) 在CAR T细胞中的CD5基因.
- 在各种血液学和固体癌症模型中评估了CAR T细胞激活,细胞毒性,体内扩张和持久性.
主要成果:
- CD5被确定为CAR T细胞激活的抑制剂.
- CD5 KO显著增强了CAR T细胞效应因子功能,包括增加细胞毒性,体内扩张和持久性.
- CD5 KO在多种血液学和固体癌症模型中表现出强大的抗瘤作用,在临床前环境中没有明显的毒性.
结论:
- 在CAR T细胞治疗的背景下,CD5是T细胞功能的关键负调节者.
- 通过基因淘汰等方法向CD5,是克服CAR T细胞功能障碍和改善各种癌症治疗结果的有希望的策略.
相关概念视频
Tumor Immunotherapy
504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504
T Cell Activation and Clonal Selection
696
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
696
Cytotoxic T Cells-mediated Immune Response
885
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
885
T Cell Types and Functions
990
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
990
Cell-mediated Immune Responses
68.0K
Overview
68.0K


